Struggling with Gut Health?
If you’re dealing with constipation, you’re not alone. It can stem from various factors: certain vitamins, dehydration, or even not getting enough exercise. But what’s intriguing is that there might be a microscopic element at play—specifically, the types of bacteria that reside in your intestines.
An imbalance among gut bacteria can lead to a slew of issues, like irritable bowel syndrome, bloating, and yes, constipation. Recent research from Japan has pointed to two common bacteria that, when present in large numbers, might negatively impact your bathroom visits.
Studies published in scientific journals have identified two bacteria that, while not harmful by themselves, can create issues when they work together. They both contribute to softening stool and thinning the protective mucus layer in the intestines, which is crucial for smooth transit.
These two are Akkermansia muciniphila and Bacteroides thetaiotaomicron. Typically found in the gut, problems arise when their levels get too high. This situation leads to a condition referred to as “bacterial constipation,” characterized by the thinning and drying of natural intestinal lubricants.
Interestingly, under normal circumstances, both bacteria play essential roles in healthy intestinal function. The mucus layer aids in retaining moisture, lubricating stool, while also acting as a barrier between the intestinal lining and gut bacteria.
A. muciniphila consumes colon mucin, which contains a sulfate tag that most bacteria can’t penetrate. That’s where B. thetaiotaomicron steps in, producing an enzyme that removes this tag, allowing A. muciniphila to do its job. However, as time goes on, mucin can become diluted, leading to drier stools and slower bowel movements.
This bacterial imbalance is frequently observed in patients with Parkinson’s disease and those experiencing chronic idiopathic constipation.
To delve deeper into how this happens, researchers experimented with mice that lacked gut bacteria. Those given only one of the two bacteria showed no signs of constipation, while mice fed both displayed drier stools and reduced mucin levels.
Furthermore, removing a specific gene from B. thetaiotaomicron made the intestinal mucin less susceptible to bacterial invasion, thanks to its sulfatase activity.
There’s a suggestion that monitoring levels of A. muciniphila in fecal samples might help identify individuals more susceptible to this type of constipation, especially when analyzed alongside levels of their bacterial partner.
